Bonjour / Se connecter
Faire un don
| Médecins |


  • Médecine interne - Oncologie (Université de Liège, 1992)

Centres d'intérêt

  • Hématologie clinique


  • Maître de stage en médecine interne


  • Focan C, Kreutz F, Longrée L, Graas MP, Moeneclaey N, Demolin G, Focan-Henrard D. Interest of chronotherapy in multidisciplinary management of oesophageal and gastric cancers. Pathol Biol (Paris). 2007 Apr-May; 55(3-4): 181-5. 

  • Focan C, Bury J, Matus G, Graas MP, Kreutz F, Longree L, Moeneclaey N, David A, Focan-Henrard D. Adjuvant chemotherapy for Dukes B2 and C colon cancer combining 5-fluorouracil and folinic acid with or without carboplatin. Feasibility and comparison between standard and chronomodulated deliveries.Pathol Biol (Paris). 2005 Jun; 53(5): 281-4. 

  • Focan C, Kreutz F, Graas MP, Longrée L, Moeneclaey N, David A, Focan-Henrard D. Feasibility survey (Phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancer. Pathol Biol (Paris). 2005 Jun;53(5): 277-80.

  • Focan C, Kreutz F, Longrée L, Graas MP, Focan-Henrard D, Moeneclaey N, David A, Biquet JF, Materne R, Weerts J, Delforge M. Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study. Pathol Biol (Paris). 2005 Jun; 53(5): 273-6.

  • Herens C, Tassin F, Lemaire V, Beguin Y, Collard E, Lampertz S, Croisiau C, Lecomte M, De Prijk B, Longrée L, Koulischer L. Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. Br J Haematol. 2000 Jul; 110(1): 214-6.

  • Fraipont V, Sautois B, Baudoux E, Pereira M, Fassotte MF, Hermanne JP, Jérusalem G, Longrée L, Schaaf-Lafontaine N, Fillet G, Beguin Y. Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF.Transfusion. 2000 Mar; 40(3): 339-47.

  • Graas MP, Evrard P, Creemers E, Longrée L, Limet R, Focan C. Clinical case of the month. Metastatic endocarditis: clinical observation and review of the literature. Rev Med Liege. 1998 Oct; 53(10): 588-91. 

  • Mohnen L, Heedfeld T, Focan-Henrard D, Kreutz F, Longree L, Focan C. Ambulatory chrono-chemotherapy by portable pumps: feasibility and compliance. Nursing aspects. In Vivo. 1995 Nov-Dec;9(6): 565-71.

  • Longrée L, Focan C, Bury J, Beauduin M, Brohee D, Duvivier A, Lecomte M, Markiewicz S, Vindevoghel A, Weerts J. Levamisole adds granulocyte toxicity to 5FU-based chemotherapies in adjuvant treatment of Dukes B-C colorectal cancer. A preliminary report. Anticancer Res. 1995 Jul-Aug; 15(4): 1561-4.

  • Longree L, Pautier P, Guilhot F, Brice P. Pregnancy occurring during complete cytogenetic response after interferon therapy in chronic myeloid leukaemia. Nouv Rev Fr Hematol. 1995; 37(4): 249-50.